Sovereign wealth funds are pouring billions of dollars back into China after a sharp investment slump.
Over the past 18 months pharma groups, including AstraZeneca, Sana Biotechnology and Tempest Therapeutics, have pursued ...
China Life Insurance has delivered a very strong share price over the past few years, yet the recent pullback puts fresh ...
The Treasury Department’s proposed restrictions on U.S. investment in Chinese biopharma collide with Beijing’s new export ...
Citi has received long-awaited approval to operate a wholly owned securities business in China, in a move that comes ahead of ...
The gap between U.S. and Chinese stocks just broke a record stretching back decades, and Beijing's state-backed funds are still sitting on their hands while blue-chip shares slide into bear market ...
BEIJING, Oct ⁠24 (Reuters) - ⁠The Chinese commerce ⁠ministry urged the United States on ​Saturday to stop expanding restrictions on American investments ‌in China, saying a ‌proposed rule on sensitive ...
China's top anti-graft official Li Xi has called for higher standards and more concrete measures to promote high-quality disciplinary inspection work. Li, a member of the Standing Committee of the ...